.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Blogs
Cancer Horizons
Clinical Trial Corner
CURE's 20th Anniversary Celebration
Publications
Recipes
Videos

Cancer TypeSee All >

Bladder
Breast
CLL
Kidney
Lung
MCL
Ovarian
Prostate
Skin

About CURE

Press Releases
Share Your Story
Write for CURE

About
Advertise / Support
Contact
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information

Treating With Venetoclax for Chronic Lymphocytic Leukemia: Samantha’s Story

EP. 1: The First Signs of Leukemia

October 14th 2020

EP. 2: Chronic Lymphocytic Leukemia Diagnostic Process

October 14th 2020

EP. 3: CLL Treatment Decision Factors

October 14th 2020

EP. 4: First-Hand Experience with CD20 Monoclonal Antibody Therapy

October 14th 2020

EP. 5: CD20 Monoclonal Antibody Dose Adjustment and MRD

October 14th 2020

EP. 6: The Patient's Role in Deciding a Treatment

October 14th 2020

EP. 7: Achieving Minimum Residual Disease Remission

October 14th 2020

EP. 8: Chronic Lymphocytic Leukemia Support Network

October 14th 2020

EP. 9: Advice for Patient's and Caregivers

October 14th 2020

EP. 10: Lifestyle Changes After Being Diagnosed with CLL

October 14th 2020

Latest News

As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis

First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer

FDA Approves Orserdu for Some Patients with Metastatic Breast Cancer

FDA Approves Jaypirca for Relapsed/Refractory Mantle Cell Lymphoma

View More Latest News